Zentraxa Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $522K

  • Investors
  • 16

Zentraxa General Information

Description

Developer of biopolymers designed to assist various medical processes and functions. The company's biopolymers can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process and use a unique manufacturing process to produce biological adhesives, enabling clients to get assistance in various research and development processes.

Contact Information

Website
www.zentraxa.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Science Creates Saint Philips
  • Saint Phillips Central, Albert Road
  • Bristol BS2 0XJ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • Science Creates Saint Philips
  • Saint Phillips Central, Albert Road
  • Bristol BS2 0XJ
  • England, United Kingdom

Zentraxa Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zentraxa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Seed Round 27-May-2024 $522K Completed Generating Revenue
11. Accelerator/Incubator Completed Generating Revenue
10. Seed Round 15-Sep-2023 Completed Generating Revenue
9. Seed Round Completed Generating Revenue
8. Seed Round 02-Nov-2022 Completed Generating Revenue
7. Grant 01-Jan-2022 Completed Generating Revenue
6. Grant 01-Jan-2021 Completed Startup
5. Grant 01-Jan-2020 Completed Startup
4. Seed Round 22-May-2019 $647K $647K Completed Startup
3. Grant 01-Feb-2018 $96.9K Completed Startup
To view Zentraxa’s complete valuation and funding history, request access »

Zentraxa Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Preference
Ordinary
Ordinary
Ordinary 58,693 $0.001000 $16.26 $16.26 1x $16.26 24.02%
Ordinary 32,032 $0.001000 $15.62 $15.62 1x $15.62 13.11%
To view Zentraxa’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Zentraxa Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Zentraxa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202507328-D0 Adhesive peptides Pending 13-May-2025
GB-202406866-D0 Adhesive peptides Inactive 15-May-2024
GB-202307193-D0 Adhesive peptides Inactive 15-May-2023
GB-202207104-D0 Adhesive peptides Inactive 16-May-2022
EP-4251637-A1 Adhesive peptides Pending 26-Nov-2020 C07K7/06
To view Zentraxa’s complete patent history, request access »

Zentraxa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zentraxa Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Empirical Ventures Venture Capital Minority
Science Angel Syndicate Angel Group Minority
Elbow Beach Venture Capital Minority
KCP Nominees Corporation Minority
Parkwalk Advisors Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Zentraxa FAQs

  • When was Zentraxa founded?

    Zentraxa was founded in 2017.

  • Where is Zentraxa headquartered?

    Zentraxa is headquartered in Bristol, United Kingdom.

  • What is the size of Zentraxa?

    Zentraxa has 17 total employees.

  • What industry is Zentraxa in?

    Zentraxa’s primary industry is Biotechnology.

  • Is Zentraxa a private or public company?

    Zentraxa is a Private company.

  • What is the current valuation of Zentraxa?

    The current valuation of Zentraxa is .

  • What is Zentraxa’s current revenue?

    The current revenue for Zentraxa is .

  • How much funding has Zentraxa raised over time?

    Zentraxa has raised $2.5M.

  • Who are Zentraxa’s investors?

    Empirical Ventures, Science Angel Syndicate, Elbow Beach, KCP Nominees, and Parkwalk Advisors are 5 of 16 investors who have invested in Zentraxa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process